Cargando…

Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor

In the past 10 years, with the increase of investment in clinical nano-gene therapy, there are many trials that have been discontinued due to poor efficacy and serious side effects. Therefore, it is particularly important to design a suitable gene delivery system. In this paper, we introduce the app...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yao, Shi, Kun, Qu, Ying, Chu, Bingyang, Qian, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197778/
https://www.ncbi.nlm.nih.gov/pubmed/30364598
http://dx.doi.org/10.1016/j.omtm.2018.09.002